Skip to content

Randomised trial, 1986

Does menstrual cycle phase affect how women with asthma respond to anti-inflammatory medication?

Yes. Women with premenstrual asthma had acute reactions to meclofenamate during the early cycle phase but never during the late cycle phase. Prostaglandin levels were 10 times higher in the early phase.

Early or limited evidence 24 women with premenstrual asthma, 4 with regular asthma, 4 healthy women

What they did

Researchers measured prostaglandin levels and airway response to meclofenamate and metaproterenol at two cycle phases in 24 women with premenstrual asthma, 4 with regular asthma, and 4 healthy women. Each woman received a single 100 mg dose of meclofenamate and 1.5 mg of metaproterenol during the early (follicular) and late (luteal) cycle phases.

What they found

Prostaglandin averaged 140.9 pg/0.1 ml in the follicular phase but only 14.4 pg/0.1 ml in the luteal phase. Six women with premenstrual asthma had acute reactions to meclofenamate during the follicular phase but never during the luteal phase. These reactions occurred more often in women on corticosteroids. One woman had 18% improvement in lung function with meclofenamate during the luteal phase.

What it means for you

Women with premenstrual asthma may experience worse reactions to meclofenamate during the early menstrual cycle phase. This may be related to lower prostaglandin levels during the late cycle. However, this finding applies to only one medication and may be specific to women taking corticosteroids.

140.9 pg/0.1 ml

Prostaglandin in follicular phase

14.4 pg/0.1 ml

Prostaglandin in luteal phase

6 of 24

Women with premenstrual asthma with reactions to meclofenamate

About the study

Original title
Serum 13-14-diOH-15-keto-prostaglandin F2 alpha and airway response to meclofenamate and metaproterenol in relation to the menstrual cycle
Authors
Eliasson O, Longo M, Dore-Duffy P et al.
Journal
The Journal of asthma : official journal of the Association for the Care of Asthma
Year
1986
Study design
Randomised trial
Participants
24
What was tested
Single dose of 100 mg oral meclofenamate and 1.5 mg inhaled metaproterenol at follicular and luteal cycle phases

Topics